-
Cadila gets five observations from US FDA
expressbpd
August 30, 2018
Cadila Healthcare said the US health regulator has issued five observations after inspection of its subsidiary Liva Pharmaceuticals’ injectables manufacturing facility. “This was a product specific pre-approval inspection.......
-
Cadila scores FDA approval for BMS and Alvogen generics
pharmafile
July 06, 2018
The India-based company will manufacture nifedipine ER, a generic equivalent of Alvogen’s Adolat, at its Moraiya manufacturing facility in Gujurat, India.
-
Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antith
b3cnewswire
September 20, 2017
Helsinki, Finland and Stockholm, Sweden, Aplagon Oy (“Aplagon”) and Cadila Pharmaceuticals Sweden AB today announced a development and commercialization agreement for Aplagon’s lead APAC product.
-
Cadila gets board approval to raise Rs 18,500 cr
expressbpd
June 29, 2017
Board also approved issuing foreign currency bonds/ foreign currency convertible bonds
-
Cadila Pharmaceuticals observes World TB Day
financialexpress
March 27, 2017
Multi-city patient awareness programmes, free diagnosis, cyclothon, radio and film activities were conducted to raise awareness on the killer disease
-
Cadila Healthcare in pact with Supernus Pharmaceuticals
expressbpd
March 10, 2017
Under the terms of the pact, Supernus grants a license to market Zydus generic version of Trokendi XR (topiramate) extended-release capsules beginning on January 1, 2023
-
Cadila settles patent litigation related to Livalo tabs
expressbpd
January 18, 2017
Under the terms of the agreement, Kowa and Nissan grant Zydus a licence to market Zydus’ generic version of Livalo beginning on May 2, 2023, or earlier under certain circumstances
-
Cadila arm acquires six brands from MSD pharma
biospectrumasia
January 05, 2017
The deal includes transfer of distribution and commercialisation rights and assignment of trademarks of all the six brands to Zydus Healthcare Limited in India